| Effect of omega-3 fatty acids on cardiovascular outcomes: A systematic review and meta-analysis SU Khan, AN Lone, MS Khan, SS Virani, RS Blumenthal, K Nasir, M Miller, ... EClinicalMedicine 38, 2021 | 236 | 2021 |
| Effects of nutritional supplements and dietary interventions on cardiovascular outcomes: an umbrella review and evidence map SU Khan, MU Khan, H Riaz, S Valavoor, D Zhao, L Vaughan, ... Annals of internal medicine 171 (3), 190-198, 2019 | 198 | 2019 |
| Dual antiplatelet therapy after percutaneous coronary intervention and drug-eluting stents: a systematic review and network meta-analysis SU Khan, M Singh, S Valavoor, MU Khan, AN Lone, MZ Khan, MS Khan, ... Circulation 142 (15), 1425-1436, 2020 | 164 | 2020 |
| Social determinants of health and cardiovascular disease: current state and future directions towards healthcare equity MH Jilani, Z Javed, T Yahya, J Valero-Elizondo, SU Khan, B Kash, ... Current atherosclerosis reports 23, 1-11, 2021 | 150 | 2021 |
| Effects of influenza vaccine on mortality and cardiovascular outcomes in patients with cardiovascular disease: a systematic review and meta‐analysis SH Yedlapati, SU Khan, S Talluri, AN Lone, MZ Khan, MS Khan, ... Journal of the American Heart Association 10 (6), e019636, 2021 | 149 | 2021 |
| A meta-analysis of continuous positive airway pressure therapy in prevention of cardiovascular events in patients with obstructive sleep apnoea SU Khan, CA Duran, H Rahman, M Lekkala, MA Saleem, E Kaluski European heart journal 39 (24), 2291-2297, 2018 | 142 | 2018 |
| Comparative Efficacy and Safety of Oral P2Y12 Inhibitors in Acute Coronary Syndrome: Network Meta-Analysis of 52 816 Patients From 12 Randomized Trials EP Navarese, SU Khan, M Kołodziejczak, J Kubica, S Buccheri, ... Circulation 142 (2), 150-160, 2020 | 141 | 2020 |
| Ten‐year trends in enrollment of women and minorities in pivotal trials supporting recent US food and drug administration approval of novel cardiometabolic drugs MS Khan, I Shahid, TJ Siddiqi, SU Khan, HJ Warraich, SJ Greene, J Butler, ... Journal of the American heart association 9 (11), e015594, 2020 | 139 | 2020 |
| Participation of women and older participants in randomized clinical trials of lipid-lowering therapies: a systematic review SU Khan, MZ Khan, CR Subramanian, H Riaz, MU Khan, AN Lone, ... JAMA Network Open 3 (5), e205202-e205202, 2020 | 115 | 2020 |
| Gender differences in patient‐reported outcomes among adults with atherosclerotic cardiovascular disease V Okunrintemi, J Valero‐Elizondo, B Patrick, J Salami, M Tibuakuu, ... Journal of the American Heart Association 7 (24), e010498, 2018 | 115 | 2018 |
| Social vulnerability and premature cardiovascular mortality among US counties, 2014 to 2018 SU Khan, Z Javed, AN Lone, SS Dani, Z Amin, SG Al-Kindi, SS Virani, ... Circulation 144 (16), 1272-1279, 2021 | 113 | 2021 |
| Impact of social vulnerability on comorbid cancer and cardiovascular disease mortality in the United States S Ganatra, SS Dani, A Kumar, SU Khan, R Wadhera, TG Neilan, ... Cardio Oncology 4 (3), 326-337, 2022 | 106 | 2022 |
| Stroke in young adults: Current trends, opportunities for prevention and pathways forward T Yahya, MH Jilani, SU Khan, R Mszar, SZ Hassan, MJ Blaha, ... American journal of preventive cardiology 3, 100085, 2020 | 92 | 2020 |
| Level and prevalence of spin in published cardiovascular randomized clinical trial reports with statistically nonsignificant primary outcomes: a systematic review MS Khan, N Lateef, TJ Siddiqi, KA Rehman, S Alnaimat, SU Khan, H Riaz, ... JAMA network open 2 (5), e192622-e192622, 2019 | 87 | 2019 |
| Use of balloon atrial septostomy in patients with advanced pulmonary arterial hypertension: a systematic review and meta-analysis MS Khan, MM Memon, E Amin, N Yamani, SU Khan, VM Figueredo, ... Chest 156 (1), 53-63, 2019 | 80 | 2019 |
| Remdesivir for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials A Al-Abdouh, A Bizanti, M Barbarawi, A Jabri, A Kumar, OE Fashanu, ... Contemporary clinical trials 101, 106272, 2021 | 74 | 2021 |
| PCSK9 inhibitors and ezetimibe with or without statin therapy for cardiovascular risk reduction: a systematic review and network meta-analysis SU Khan, SH Yedlapati, AN Lone, Q Hao, G Guyatt, N Delvaux, ... bmj 377, 2022 | 72 | 2022 |
| Association of lowering low‐density lipoprotein cholesterol with contemporary lipid‐lowering therapies and risk of diabetes mellitus: a systematic review and meta‐analysis SU Khan, H Rahman, V Okunrintemi, H Riaz, MS Khan, S Sattur, ... Journal of the American Heart Association 8 (7), e011581, 2019 | 71 | 2019 |
| Application of the reverse fragility index to statistically nonsignificant randomized clinical trial results MS Khan, GC Fonarow, T Friede, N Lateef, SU Khan, SD Anker, ... JAMA Network Open 3 (8), e2012469-e2012469, 2020 | 69 | 2020 |
| Utility of the CHA2DS2-VASc score for predicting ischaemic stroke in patients with or without atrial fibrillation: a systematic review and meta-analysis TJ Siddiqi, MS Usman, I Shahid, J Ahmed, SU Khan, L Ya’qoub, CS Rihal, ... European Journal of Preventive Cardiology 29 (4), 625-631, 2022 | 65 | 2022 |